Dose Escalation Improves Cancer-Related Events at 10 Years for Intermediate- and High-Risk Prostate Cancer Patients Treated With Hypofractionated High-Dose-Rate Boost and External Beam Radiotherapy

Author(s):  
Alvaro A. Martinez ◽  
Jose Gonzalez ◽  
Hong Ye ◽  
Mihai Ghilezan ◽  
Sugandh Shetty ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document